Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma

Pathology International

Volumn 63, Issue 12, 2013, Pages 573-580

  Chuang, Huei Chieh ^a   Hsu, Sheng Chi ^b   Huang, Chung Guei ^a   Hsueh, Swei ^a   Ng, Kwai Fong ^a   Chen, Tse Ching ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

18); Immunohistochemistry; Molecular diagnosis; Scoring system; SS18; SSX; Synovial sarcoma; T(X; TLE 1

Indexed keywords

TLE 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CHONDROSARCOMA; CLINICAL PRACTICE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOMETRIUM SARCOMA; EWING SARCOMA; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MESOTHELIOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; SOLITARY FIBROUS TUMOR; SYNOVIAL SARCOMA; TLE 1 IMMUNOHISTOCHEMICAL STAINING;

18); IMMUNOHISTOCHEMISTRY; MOLECULAR DIAGNOSIS; SCORING SYSTEM; SS18; SSX; SYNOVIAL SARCOMA; T(X; TLE-1;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; REPRESSOR PROTEINS; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 84892456198     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12113     Document Type: Article

References (27)

1. Suurmeijer AJH, de Bruijn D, Geurts van Kessel A, Miettinen MM. Synovial sarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone (WHO Health Organization Classification of Tumours). France: IARC publishing, 2012; 213-215.
2. Haldar M, Randall RL, Capecchi MR. Synovial sarcoma: From genetics to genetic-based animal modeling. Clin Orthop Relat Res 2008; 466: 2156-2167.
3. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet 2002; 133: 1-23.
4. Kind M, Stock N, Coindre JM. Histology and imaging of soft tissue sarcomas. Eur J Radiol 2009; 72: 6-15.
5. Van Vliet M, Kliffen M, Krestin GP, van Dijke CF. Soft tissue sarcomas at a glance: Clinical, histological, and MR imaging features of malignant extremity soft tissue tumors. Eur Radiol 2009; 19: 1499-1511.
6. Matsuyama A, Hisaoka M, Iwasaki M, Iwashita M, Hisanaga S, Hashimoto H. TLE1 expression in malignant mesothelioma. Virchows Arch 2010; 457: 577-583.
7. van de Rijn M, Barr FG, Xiong QB, Hedges M, Shipley J, Fisher C. Poorly differentiated synovial sarcoma: An analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol 1999; 23: 106-112.
8. Terry J, Saito T, Subramanian S etal. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol 2007; 31: 240-246.
9. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006; 19: 659-668.
10. Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Am J Surg Pathol 2009; 33: 1743-1751.
11. Knösel T, Heretsch S, Altendorf-Hofmann A etal. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): Analysis of 319 cases. Eur J Cancer 2010; 46: 1170-1176.
12. Kosemehmetoglu K, Vrana JA, Folpe AL. TLE1 expression is not specific for synovial sarcoma: A whole section study of 163 soft tissue and bone neoplasms. Mod Pathol 2009; 22: 872-878.
13. Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol 2011; 135: 839-844.
14. Amary MF, Berisha F, Bernardi Fdel C etal. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: Analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol 2007; 20: 482-496.
15. Malignant soft tissue tumors of uncertain type. In: Weiss SW, Goldblum JR, Folpe AL, eds. Enzinger and Weiss's Soft Tissue Tumors, 5th edn. Philadelphia, PA: Mosby-Elsevier, 2007; 1161-1182.
16. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: Immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998; 22: 673-682.
17. Valente AL, Tull J, Zhang S. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma. Appl Immunohistochem Mol Morphol 2013; 21: 408-413.
18. Ten Heuvel SE, Hoekstra HJ, Suurmeijer AJ. Diagnostic accuracy of FISH and RT-PCR in 50 routinely processed synovial sarcomas. Appl Immunohistochem Mol Morphol 2008; 16: 246-250.
19. Liu Y, Dehni G, Purcell KJ etal. Epithelial expression and chromosomal location of human TLE genes: Implications for notch signaling and neoplasia. Genomics 1996; 31: 58-64.
20. Seo SW, Lee H, Lee HI, Kim HS. The role of TLE1 in synovial sarcoma. J Orthop Res 2011; 29: 1131-1136.
21. Chen G, Courey AJ. Groucho/TLE family proteins and transcriptional repression. Gene 2000; 249: 1-16.
22. Yochum GS, Ayer DE. Pf1, a novel PHD zinc finger protein that links the TLE corepressor to the mSin3A-histone deacetylase complex. Mol Cell Biol 2001; 21: 4110-4118.
23. Ito T, Ouchida M, Morimoto Y etal. Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. Cancer Lett 2005; 224: 311-319.
24. Ito T, Ouchida M, Ito S etal. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex. Lab Invest 2004; 84: 1484-1490.
25. Rdzanek M, Fresco R, Pass HI, Carbone M. Spindle cell tumors of the pleura: Differential diagnosis. Semin Diagn Pathol 2006; 23: 44-55.
26. Su L, Sampaio AV, Jones KB etal. Deconstruction of the SS18-SSX fusion oncoprotein complex: Insights into disease etiology and therapeutics. Cancer Cell 2012; 21: 333-347.
27. Jones KB, Su L, Jin H etal. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas. Oncogene 2013; 32: 2365-2371.